EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional assay for assessment of pathogenicity of BAP1 variants

Pauliina E Repo iD, Michael P Backlund, Tero T Kivelä, Joni A Turunen iD

Human Molecular Genetics · 2024

DOI: 10.1093/hmg/ddad193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Pauliina E Repo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Eye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290, Helsinki, Finland. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Uveal Neoplasms, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helsinki University Hospital Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathogenic germline variants in BRCA1-Associated Protein 1 (BAP1) cause BAP1 tumor predisposition syndrome (BAP1-TPDS). Carriers run especially a risk of uveal (UM) and cutaneous melanoma, malignant mesothelioma, and clear cell renal carcinoma. Approximately half of increasingly reported BAP1 variants lack accurate classification. Correct interpretation of pathogenicity can improve prognosis of the patients through tumor screening with better understanding of BAP1-TPDS.

Methods

We edited five rare BAP1 variants with differing functional characteristics identified from patients with UM in HAP1 cells using CRISPR-Cas9 and assayed their effect on cell adhesion/spreading (at 4 h) and proliferation (at 48 h), measured as cell index (CI), using xCELLigence real-time analysis system.

Results

In BAP1 knockout HAP1 cultures, cell number was half of wild type (WT) cultures at 48 h (p = 0.00021), reaching confluence later, and CI was 78% reduced (p < 0.0001). BAP1-TPDS-associated null variants c.67+1G>T and c.1780_1781insT, and a likely pathogenic missense variant c.281A>G reduced adhesion (all p ≤ 0.015) and proliferation by 74%–83% (all p ≤ 0.032). Another likely pathogenic missense variant c.680G>A reduced both by at least 50% (all p ≤ 0.032), whereas cells edited with likely benign one c.1526C>T grew similarly to WT.

Conclusions

BAP1 is essential for optimal fitness of HAP1 cells. Pathogenic and likely pathogenic BAP1 variants reduced cell fitness, reflected in adhesion/spreading and proliferation properties. Further, moderate effects were quantifiable. Variant modelling in HAP1 with CRISPR-Cas9 enabled functional analysis of coding and non-coding region variants in an endogenous expression system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaSkin NeoplasmsUveal NeoplasmsKidney NeoplasmsHumansVirulenceGenetic Predisposition to DiseaseGerm-Line MutationUbiquitin ThiolesteraseTumor Suppressor Proteins

Stichwörter der Autor:innen

BAP1BAP1-TPDSHAP1uveal melanomavariant interpretation

Substanzen

Ubiquitin ThiolesteraseBAP1 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Eye Genetics Group, Folkhälsan Research Center, Biomedicum Helsinki, Haartmaninkatu 8, FI-00290, Helsinki, Finland.
  • Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4 C, PL220, FI-00029 HUS, Helsinki, Finland.
  • Ophthalmic Genetics and Rare Eye Diseases Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 4 C, PL220, FI-00029 HUS, Helsinki, Finland.

ORCID-Profile: Pauliina E Repo, Joni A Turunen

Förderung

  • Helsinki University Hospital Research Fund

Zitieren

APA

Repo, P. E., Backlund, M. P., Kivelä, T. T., & Turunen, J. A. (2024). Functional assay for assessment of pathogenicity of BAP1 variants. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad193

Vancouver

Repo PE, Backlund MP, Kivelä TT, Turunen JA. Functional assay for assessment of pathogenicity of BAP1 variants. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddad193

BibTeX
@article{Repo2024,
  author = {Repo, Pauliina E and Backlund, Michael P and Kivelä, Tero T and Turunen, Joni A},
  title = {Functional assay for assessment of pathogenicity of BAP1 variants},
  journal = {Human Molecular Genetics},
  year = {2024},
  doi = {10.1093/hmg/ddad193}
}
Kostenlos starten →